PI 3-kinase p110 alpha Inhibitors
Items 21 to 25 of 25 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CAY10626 | 1202884-94-3 | sc-358741 sc-358741A | 1 mg 5 mg | $169.00 $756.00 | ||
CAY10626 is a selective inhibitor of PI 3-kinase p110 alpha, exhibiting unique binding affinity that disrupts the enzyme's catalytic activity. Its structure allows for specific interactions with the ATP-binding site, influencing downstream signaling pathways. The compound demonstrates distinct kinetic properties, with a rapid onset of action and a prolonged effect on cellular processes. This specificity enables detailed studies of cellular metabolism and growth regulation mechanisms. | ||||||
BAG 956 | 853910-02-8 | sc-291923 sc-291923A | 10 mg 50 mg | $215.00 $906.00 | ||
BAG 956 is a potent inhibitor of PI 3-kinase p110 alpha, characterized by its unique ability to modulate enzyme conformation through specific interactions with key residues in the active site. This compound alters the enzyme's reaction kinetics, leading to a significant reduction in phosphoinositide production. Its distinct molecular architecture facilitates selective engagement with regulatory domains, providing insights into cellular signaling networks and metabolic regulation. | ||||||
XL-147 derivative 1 | 1349796-36-6 | sc-364660 sc-364660A | 5 mg 50 mg | $189.00 $1725.00 | ||
XL-147 derivative 1 is a selective inhibitor of PI 3-kinase p110 alpha, distinguished by its capacity to disrupt the enzyme's dimerization process. This compound exhibits unique binding dynamics, stabilizing an inactive conformation that impedes substrate access. Its structural features allow for targeted interactions with allosteric sites, influencing downstream signaling pathways. The compound's kinetic profile reveals a slow-onset inhibition, highlighting its potential for prolonged effects on cellular metabolism. | ||||||
Compound 15e | 371943-05-4 | sc-202551 sc-202551A | 1 mg 5 mg | $51.00 $206.00 | ||
Compound 15e is a selective inhibitor of PI 3-kinase p110 alpha, characterized by its ability to modulate enzyme activity through specific interactions with the ATP-binding pocket. This compound exhibits a unique mechanism of action, promoting conformational changes that hinder catalytic function. Its distinct molecular architecture facilitates selective binding, leading to altered phosphorylation patterns in signaling cascades. The compound's reaction kinetics suggest a competitive inhibition profile, enhancing its specificity in cellular contexts. | ||||||
A66 | 1166227-08-2 | sc-364394 sc-364394A | 5 mg 50 mg | $255.00 $1455.00 | ||
A66 is a potent inhibitor of PI 3-kinase p110 alpha, distinguished by its ability to disrupt lipid kinase activity through targeted interactions with the enzyme's active site. This compound induces significant allosteric modulation, resulting in altered enzyme conformation that impedes substrate access. Its unique structural features enable selective engagement with key residues, influencing downstream signaling pathways and cellular responses. The kinetics of A66 reveal a non-competitive inhibition mechanism, underscoring its specificity in biochemical assays. | ||||||